Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001812278 | SCV001470803 | uncertain significance | not provided | 2019-09-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004967949 | SCV005505394 | uncertain significance | Inborn genetic diseases | 2024-10-25 | criteria provided, single submitter | clinical testing | The c.1492C>T (p.R498C) alteration is located in exon 11 (coding exon 11) of the SPTB gene. This alteration results from a C to T substitution at nucleotide position 1492, causing the arginine (R) at amino acid position 498 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003898268 | SCV004710755 | uncertain significance | SPTB-related disorder | 2023-11-29 | no assertion criteria provided | clinical testing | The SPTB c.1492C>T variant is predicted to result in the amino acid substitution p.Arg498Cys. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.012% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |